Vivo Opportunity Fund, L.P., 10% Owner at Crinetics Pharmaceuticals, Inc. (CRNX), sold 40,471 shares at $22.20 ($895K) on 2020-01-29, disclosed to the SEC on 2020-01-31.
Open-market sale of $895k CRNX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.20 | 369 | $8K | 0.9% |
| 2 | $22.20 | 2,673 | $59K | 6.6% |
| 3 | $22.20 | 2,673 | $59K | 6.6% |
| 4 | $22.20 | 10,878 | $241K | 27.0% |
| 5 | $22.20 | 10,878 | $241K | 27.0% |
| 6 | $22.10 | 201 |
| $4K |
| 0.5% |
| 7 | $22.10 | 1,459 | $32K | 3.6% |
| 8 | $22.10 | 5,940 | $131K | 14.7% |
| 9 | $21.70 | 143 | $3K | 0.3% |
| 10 | $21.70 | 1,037 | $23K | 2.5% |
| 11 | $21.70 | 4,220 | $92K | 10.2% |
| Total | $22.11 avg | 40,471 | $895K | 100% |
| Filing → |